Meera Brahmbhatt, MD
Dermatopathology · Marietta, GANPI 1750816716
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 77 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 18.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $807, 2.7 times the $294 reported in 2023.
Across 77 payments — averaging $24.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$339
- Sanofi$277
- LEO Pharma Inc.$208
- Novartis$190
- Incyte Corporation$175
- Arcutis Biotherapeutics, Inc.$132
- plus $536 from 11 others
What the payments were for
- Food & beverage$1,858100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 14 | $339 |
| Sanofi | 6 | $277 |
| LEO Pharma Inc. | 8 | $208 |
| Novartis | 8 | $190 |
| Incyte Corporation | 8 | $175 |
| Arcutis Biotherapeutics, Inc. | 7 | $132 |
| Dermavant Sciences, Inc. | 4 | $90 |
| Johnson & Johnson | 4 | $77 |
| Galderma Laboratories, L.p. | 3 | $57 |
| UCB, Inc. | 3 | $56 |
| Regeneron Healthcare Solutions, Inc. | 2 | $49 |
| Amgen | 2 | $46 |
| Pfizer | 2 | $45 |
| Sun Pharmaceutical Industries Inc. | 2 | $41 |
| Lilly USA, LLC | 2 | $34 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| Boehringer Ingelheim | 1 | $20 |
How this compares
$1,858 in reported general payments places this provider in the 75th percentile of 25 dermatopathology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 16 | $56,696 |
| Clobetasol Propionate | 43 | $1,977 |
| Fluorouracil | 16 | $1,108 |
| Fluocinonide | 26 | $869 |
| Triamcinolone Acetonide | 76 | $854 |
| Ketoconazole | 64 | $829 |
| Betamethasone Dipropionate | 15 | $766 |
| Desonide | 23 | $706 |
| Clindamycin Phosphate | 16 | $606 |
| Metronidazole | 13 | $514 |
| ValacyclovirValacyclovir Hcl | 11 | $274 |
| Mometasone Furoate | 18 | $267 |
| Doxycycline Hyclate | 16 | $145 |
| Hydrocortisone | 12 | $83 |
| Finasteride | 15 | $56 |
Paid to pharmacies, not to this prescriber.
Other dermatopathology in Marietta
- Kevin ThomasMarietta$343
- Douglas HuberMarietta$37
- Kathleen SmithDecatur$57K
- Drazen JukicSavannah$16K
- Dipti AnandSmyrna$11K
- Jill Buckthal-MccuinGreensboro$11K
- Gautham VellaichamyAtlanta$2K
- Andrea VolkAtlanta$497
- Paul HillesheimRome$448
- Wesley SimmsThomasville$396
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.